Skip to Content
HubMed New
  • Solutions
    • Overview
    • Adam™
    • Medea™
  • Industries
    • Overview
    • Nutraceuticals
    • Cosmetics
    • Medical Devices
    • Contract Research Organization
  • Why Hubmed™
    • Overview
    • Swiss made quality
    • Data security
    • AI-Driven Insights
    • PICO Framework
    • End-to-End Integration
  • Resources
    • Blog
    • Medea™ | Early Adopter Program
    • Medea™ | CER Maintenance Calculator
    • Medea™ | ROI & Savings
  • About Us
  • Contact Us 
HubMed New
      • Solutions
        • Overview
        • Adam™
        • Medea™
      • Industries
        • Overview
        • Nutraceuticals
        • Cosmetics
        • Medical Devices
        • Contract Research Organization
      • Why Hubmed™
        • Overview
        • Swiss made quality
        • Data security
        • AI-Driven Insights
        • PICO Framework
        • End-to-End Integration
      • Resources
        • Blog
        • Medea™ | Early Adopter Program
        • Medea™ | CER Maintenance Calculator
        • Medea™ | ROI & Savings
      • About Us
    • Contact Us 
     CROs & Medical Device Companies

    Beyond Compliance:

    Medea™ Saves Your CRO €30.000+ Every Year


    Medea™ is not just a regulatory safeguard. It is a measurable financial advantage — reducing the time your compliance team spends on every Clinical Evaluation Report by up to 70% on the most labour-intensive activities.


    Apply for Early Access


    Baseline Assumptions

    How We Built the Model


    MODEL PARAMETERS

    Each Clinical Evaluation Report (CER) requires an average of 120 hours of work by a CRO or Medical Device compliance team (actual time varies by device class and complexity). Of this total, approximately 35% — i.e. 42 hours per CER — is dedicated to the research-intensive phase: systematic literature review, evidence appraisal, risk-benefit analysis, and technical annexes. This is precisely where Medea™ intervenes with the greatest impact. The remaining 65% (78 hours) is spent drafting and customising the CER narrative according to company-specific guidelines.


    CER Time Allocation — 120 Hours Total

    35% — 42 hrs Research Phase
    65% — 78 hrs Drafting & Customisation
    Research phase (lit. review, appraisal, risk-benefit, annexes) — Medea® impact zone
    CER drafting & company customisation



    Medea® Efficiency Gain

    Medea™ reduces the research phase time by 70%, cutting 42 hours down to just 12,6 hours per CER — saving 29,4 hours of high-value compliance work on every single report.

    -70%
    Research Phase Time

    Step-by-Step Calculation

    From Hours Saved to Net Annual Saving?


    1 - Research Phase

    Hours Dedicated to Research per CER

    120 total hours × 35% = research-intensive activities (literature review, evidence appraisal, risk-benefit analysis, technical annexes)

    42 hrs
    per CER


    2 - Medea® Time Saving

    Hours Saved per CER with Medea

    Medea automates and accelerates 70% of the research phase: 42 hrs × 70% = hours recovered per CER, available for higher-value activities

    29,4 hrs
    saved per CER


    3 - Gross Saving per CER

    Labour Cost Saving per CER

    29,4 hrs × €40/hr (exitimated average compliance specialist hourly rate) = gross monetary saving on each CER produced with Medea

    €1.176
    gross per CER


    4 - Monthly Volume (Baseline)

    Gross Monthly Saving (2 CERs/month)

    A CRO producing 2 CERs per month — a conservative baseline for an active regulatory team — generates: €1.176 × 2 = gross monthly labour saving

    €2.352
    gross /month


    5 - Net Saving After Licence

    Net Monthly Saving After Medea Licence

    Calculated after accounting for the monthly Medea subscription = net saving retained by the CRO each month

    €1.362
    net /month

    €1.362
    Net Monthly Saving

     x  12
    Months per Year

    =   €16.344
    Minimum Net Annual Saving per CRO


    Bottom Line — Net Annual ROI


    Every CRO Using Medea™ Saves a Minimum of €16.344 per Year

    This is a conservative baseline estimate, calculated on just 2 CERs per month. CROs with higher CER volumes, more complex devices, or higher hourly labour rates will realise proportionally greater savings. The licence cost is recovered within the first month of operation.

    €16.344
    minimum net saving / year

    The More CERs You Produce, the Greater the Return

    Baseline CRO

    €16.344

    2 CERs/month

    Net saving after licence

    = €1.362/month × 12

    Mid-Size CRO

    €44.568

    4 CERs/month

    Net saving after licence

    = €3.714/month × 12

    Large CRO

    €72.792

    6 CERs/month

    Net saving after licence

    = €6.066/month × 12

    The Full Medea® Value Proposition


    Two Dimensions of Value — One Platform


    Regulatory Protection


    Structural MDR Compliance Safeguard

    • Traceable & Auditable Literature Reviews: Flawless automated parsing across MEDLINE/PubMed and Embase eliminates systematic evidence gaps.
    • EU MDR Annex XIV-Aligned: Built natively around the precise structures required by European regulators.
    • Liability & Asset Shielding: Protects your organization against severe documentation fines of up to €140.000.
    • Permanent Audit Readiness: Transforms technical files from a recurring corporate emergency into a continuous, standard operational state

    Financial Return


    Measurable Cost Saving from Day One

    • €16,344+ Minimum Net Annual Saving (Baseline)

    • Linear Scale-Up Economy: Your operational software cost stays fixed while your returns scale with your volume.
    • Day-One Labor Savings: Immediate reduction of up to 70% in the core research timelines per technical file.
    • Instant Cost Recovery: The full platform license is offset within the very first month of deployment.
    • Capacity Optimization: Frees your regulatory and clinical experts from administrative fatigue, allowing them to focus on high-impact activities.

    Start Saving €16K+ from Month One

    Join the exclusive Medea™ Early Adopter Program before our formal launch. Secure founding partner rates and start building an audit-proof portfolio.

    Official launch: June 21, 2026.

    Apply to the EAP Program    

    Talk to a Sales Expert

    USEFUL LINKS
    • Home
    • Solutions
    • Industries
    • Why Hubmed™
    • About us
      Privacy Policy
    • Contact us
    ABOUT US

    HubMed™ is a Swiss-engineered AI platform that accelerates the life science R&D lifecycle by bridging preclinical discovery (Adam™ ) with clinical regulatory compliance (Medea™ ). 

    It automates complex documentation and literature analysis to reduce development timelines by up to 70% while ensuring audit-proof evidence for the Nutraceutical, Cosmetic, and Medical Device sectors.

    CONNECT WITH US
    • Contact us
    • info@hubmed.ch

    Follow us
    2026 Copyright © HubMed™ Technologies GmBh  |  Accelerating Discovery, Ensuring Complaince
    Powered by Odoo - Create a free website